VivoSim Labs (VIVS) Cash & Equivalents (2010 - 2026)

VivoSim Labs' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $5.0 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 55.59% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (down 55.59% YoY), while the FY2026 annual figure was $5.0 million, down 55.59% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $5.0 million, up from $4.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $28.7 million in Q1 2022, with the low at $1.2 million in Q4 2024.
• The 5-year median for Cash & Equivalents is $7.6 million (2023), against an average of $9.8 million.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents slumped 81.04% in 2024, then soared 289.93% in 2025.
• VivoSim Labs' Cash & Equivalents stood at $20.2 million in 2022, then slumped by 73.78% to $5.3 million in 2023, then tumbled by 78.07% to $1.2 million in 2024, then soared by 269.34% to $4.3 million in 2025, then rose by 17.16% to $5.0 million in 2026.
• Business Quant data shows VIVS's Cash & Equivalents at $5.0 million in Q1 2026, $4.3 million in Q4 2025, and $6.7 million in Q3 2025.